These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12452171)

  • 1. Beta-blockers work as well in women as in men.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Apr; 13(7):5-7. PubMed ID: 12452171
    [No Abstract]   [Full Text] [Related]  

  • 2. Heart failure in women.
    Silber DH
    Curr Womens Health Rep; 2003 Apr; 3(2):104-9. PubMed ID: 12628079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk reduction of acute heart failure with initial administration of beta-blockers].
    Med Monatsschr Pharm; 2007 Apr; 30(4):158. PubMed ID: 17484449
    [No Abstract]   [Full Text] [Related]  

  • 4. Heart failure and its treatment in women. Role of hypertension, diabetes, and estrogen.
    Regitz-Zagrosek V; Lehmkuhl E
    Herz; 2005 Aug; 30(5):356-67. PubMed ID: 16132238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blockers for the treatment of congestive heart failure.
    Johnson S; Newton W
    J Fam Pract; 1999 Apr; 48(4):247-8. PubMed ID: 10229240
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the outcome in men and women with chronic heart failure.
    De Feo S; Opasich C
    Ital Heart J; 2003 Aug; 4(8):511-3. PubMed ID: 14564974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical issues relating to international differences in clinical trials.
    O'Shea JC; DeMets DL
    Am Heart J; 2001 Jul; 142(1):21-8. PubMed ID: 11431652
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)).
    Böhm M; Maack C; Wehrlen-Grandjean M; Erdmann E
    Z Kardiol; 2003 Aug; 92(8):668-76. PubMed ID: 12955414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heart failure studies are transferrable to everyday practice. No fear of beta blockers!].
    MMW Fortschr Med; 2002 Oct; 144(44):56. PubMed ID: 12494606
    [No Abstract]   [Full Text] [Related]  

  • 10. Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.
    Caro JJ; Migliaccio-Walle K; O'Brien JA; Nova W; Kim J; Hauch O; Hillson E; Wedel H; Hjalmarson A; Gottlieb S; Deedwania PC; Wikstrand J;
    J Card Fail; 2005 Dec; 11(9):647-56. PubMed ID: 16360958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic].
    Pölzl G; Gouya G; Hügel H; Frick M; Ulmer H; Pachinger O
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):833-9. PubMed ID: 12503474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).
    Gullestad L; Wikstrand J; Deedwania P; Hjalmarson A; Egstrup K; Elkayam U; Gottlieb S; Rashkow A; Wedel H; Bermann G; Kjekshus J;
    J Am Coll Cardiol; 2005 Jan; 45(2):252-9. PubMed ID: 15653024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Do women receive as good treatment for heart diseases as men?].
    Risøe C; Graff-Iversen S
    Tidsskr Nor Laegeforen; 2006 Mar; 126(6):785-7. PubMed ID: 16541174
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.
    Deedwania PC; Giles TD; Klibaner M; Ghali JK; Herlitz J; Hildebrandt P; Kjekshus J; Spinar J; Vitovec J; Stanbrook H; Wikstrand J;
    Am Heart J; 2005 Jan; 149(1):159-67. PubMed ID: 15660048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Cardicor as first-line therapy in heart failure : CiBis iii.
    Cardiovasc J Afr; 2009; 20(1):78. PubMed ID: 19382368
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure].
    Di Lenarda A
    Ital Heart J Suppl; 2000 Aug; 1(8):1063-5. PubMed ID: 10993017
    [No Abstract]   [Full Text] [Related]  

  • 17. [Longevity promoting beta blocker. Soon in 1st place in heart failure?].
    MMW Fortschr Med; 2003 Sep; 145(37):60. PubMed ID: 14584447
    [No Abstract]   [Full Text] [Related]  

  • 18. [Beta blockers in heart failure. Start with low and slowly increase the dosage!].
    MMW Fortschr Med; 2002 Sep; 144(38):59. PubMed ID: 12395713
    [No Abstract]   [Full Text] [Related]  

  • 19. [Beginning therapy of heart failure with beta blockers. Do these patients survive longer?].
    MMW Fortschr Med; 2005 Sep; 147(39):10. PubMed ID: 16245769
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice.
    Go AS; Yang J; Gurwitz JH; Hsu J; Lane K; Platt R
    Arch Intern Med; 2008 Dec; 168(22):2415-21. PubMed ID: 19064823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.